HIV-1 protease inhibitors and the MDR1 multidrug transporter

被引：56

作者：

Lee, CGL ^{[1
]}

Gottesman, MM ^{[1
]}

机构：

[1] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 1998年 / 101卷 / 02期

关键词：

D O I：

10.1172/JCI2575

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：287 / 288

页数：2

共 13 条

[1] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].

Chun, TW ;

Stuyver, L ;

Mizell, SB ;

Ehler, LA ;

Mican, JAM ;

Baseler, M ;

Lloyd, AL ;

Nowak, MA ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197

[2] THE 3 MOUSE MULTIDRUG RESISTANCE (MDR) GENES ARE EXPRESSED IN A TISSUE-SPECIFIC MANNER IN NORMAL MOUSE-TISSUES [J].

CROOP, JM ;

RAYMOND, M ;

HABER, D ;

DEVAULT, A ;

ARCECI, RJ ;

GROS, P ;

HOUSMAN, DE .

MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (03) :1346-1350

[3] 2 MEMBERS OF THE MOUSE MDR GENE FAMILY CONFER MULTIDRUG RESISTANCE WITH OVERLAPPING BUT DISTINCT DRUG SPECIFICITIES [J].

DEVAULT, A ;

GROS, P .

MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (04) :1652-1663

[4]

DRACH D, 1992, BLOOD, V80, P2729

[5] Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [J].

Finzi, D ;

Hermankova, M ;

Pierson, T ;

Carruth, LM ;

Buck, C ;

Chaisson, RE ;

Quinn, TC ;

Chadwick, K ;

Margolick, J ;

Brookmeyer, R ;

Gallant, J ;

Markowitz, M ;

Ho, DD ;

Richman, DD ;

Siliciano, RF .

SCIENCE, 1997, 278 (5341) :1295-1300

[6] BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].

GOTTESMAN, MM ;

PASTAN, I .

ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427

[7] Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: Correlation with clinical outcome [J].

Kaczorowski, S ;

Ochocka, M ;

Kaczorowska, M ;

Aleksandrowicz, R ;

Matysiakl, M ;

Karwacki, M .

LEUKEMIA & LYMPHOMA, 1995, 20 (1-2) :143-152

[8] The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors [J].

Kim, RB ;

Fromm, MF ;

Wandel, C ;

Leake, B ;

Wood, AJJ ;

Roden, DM ;

Wilkinson, GR .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :289-294

[9] Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833 [J].

Mayer, U ;

Wagenaar, E ;

Dorobek, B ;

Beijnen, JH ;

Borst, P ;

Schinkel, AH .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2430-2436

[10] Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins [J].

Schinkel, AH ;

Mayer, U ;

Wagenaar, E ;

Mol, CAAM ;

vanDeemter, L ;

Smit, JJM ;

vanderValk, MA ;

Voordouw, AC ;

Spits, H ;

vanTellingen, O ;

Zijlmans, JMJM ;

Fibbe, WE ;

Borst, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :4028-4033

← 1 2 →